EMEA-000181-PIP01-08-M03

Key facts

Invented name
Sativex
Active substance
Cannabidiol, delta-9-tetrahydrocannabinol
Therapeutic area
Neurology
Decision number
P/0316/2016
PIP number
EMEA-000181-PIP01-08-M03
Pharmaceutical form(s)
Oromucosal spray
Condition(s) / indication(s)
Spasticity
Route(s) of administration
Oral use
Contact for public enquiries
GW Pharma Ltd
United Kingdom
Tel. +44 (0)1223 266800
Fax +44 (0)1223 235667
E-mail: medinfo@gwpharm.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating
1 rating